Hostname: page-component-586b7cd67f-rcrh6 Total loading time: 0 Render date: 2024-11-26T09:46:05.806Z Has data issue: false hasContentIssue false
  • English
  • Français

Cost Containment in Infection Control: Ethical Problems in Rationing Medical Care

Published online by Cambridge University Press:  02 January 2015

Ruth Macklin
Ruth Macklin*
Affiliation:
Albert Einstein College of Medicine, Bronx, New York
*
Department of Epidemiology and Social Medicine, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461
Get access Rights & Permissions [Opens in a new window]

Extract

The era of cost containment is upon us. Bureaucrats and regulators, politicians and insurance administrators have begun to devise schemes for reducing the costs of hospital care and medical services in a country justly proud of the quality of its health care. The term “cost containment” has a neutral ring to it, a tone deliberately chosen by policy makers to soften the impact of its effects. The concept has an aura of virtue, conjuring an image of overflowing expenditures that must be put back into the container. But let us recognize the harsh reality that cost containment is simply another term for rationing, a notion that has somewhat unsavory connotations.

The need to embark on rationing arises when a crisis of available goods or services is imminent. We are told that too much money is being spent today on health care in the US. Since spending too much on anything is considered wasteful, and since wastefulness is at least an inefficient, if not an unethical way to treat resources, the conclusion seems inescapable that there is a moral imperative to cut costs in the health care sector. To be sure, the goals of eliminating waste and reducing excessive costs should be pursued by hospitals and physicians alike. But let us not hide behind these noble goals and accept uncritically the idea that to increase efficiency in delivering health care, it is necessary to embark on rationing schemes.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 6 , Issue 9 , September 1985 , pp. 375 - 380
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1985

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

References

1.Schwartz, DH: Ethical Questions in the Allocation of Health Resources. Presented at the American Public Health Association Conference, Anaheim, California, November 11, 1984.Google Scholar
2.Fuchs, VR: The “rationing” of medical care. N Engl J Med 1984;311:1572–1573.CrossRefGoogle Scholar
3.Levinsky, NG: The doctor's master. N Engl J Med 1984;311:1573.CrossRefGoogle ScholarPubMed
4.Thurow, LC: Learning to say “no.” N Engl J Med 1984;311:1571.CrossRefGoogle Scholar

References:

1.CDC. Systemic allergic reactions following immunization with human diploid cell rabies vaccine. MMWR 33:185–7 (1984)Google Scholar
2.CDC. Recommendations of the Immunization Practices Advisory Committee (ACIP). Rabies Prevention–United States, 1984. MMWR 33:393-402, 407–8 (1984)Google Scholar
3.Rubin, , Hattwick, MAW, Jones, S, Gregg, MB, Schwartz, VD. Adverse reactions to duck embryo rabies vaccine. Ann Intern Med 75:643–9 (1973)CrossRefGoogle Scholar
4.Boe, E, Nyland, H. Guillain-Barre syndrome after vaccination with human diploid cell rabies vaccine. Scand J Infect Dis 12:231–2 (1980)CrossRefGoogle ScholarPubMed
5.CDC. Adverse reactions to human diploid cells rabies vaccine. MMWR 29:609–10 (1980).Google Scholar
6.Bernard, KW, Smith, PW, Kader, FJ, Moran, MJ. Neuroparalytic illness and human diploid cell rabies vaccine. JAMA 245:3136–8 (1982)CrossRefGoogle Scholar
7.Varner, MW, McGuinness, GA, Galask, RP. Rabies vaccination in pregnancy. Am J of Obst and Gyn 343:717–8 (1982)CrossRefGoogle Scholar
8.Greenberg, M, Childress, J. Vaccination against rabies with duck embryo and Semple vaccines. JAMA 173:333–7(1960)CrossRefGoogle ScholarPubMed

References:

1.Fudenberg, H.H.Sensitization to immunoglobulins and hazards of gamma globulin therapy, pp 211–220 in Merler, E., Editor, Immunoglobulins: biologic aspects and clinical uses. National Academy of Sciences, Wash., D.C., 1970.Google Scholar
2.Pineda, A.A. and Taswell, H.F.Transfusion reactions associated with anti-IgA antibodies: Report of four cases and review of the literature. Transfusion 15:10–15 (1975).CrossRefGoogle ScholarPubMed
3.Janeway, C.A., Rosen, F.S.The gamma globulins. IV. Therapeutic uses of gamma globulins. N Engl J Med 275:826–831 (1966).CrossRefGoogle ScholarPubMed
4.Kjellman, H. Adverse reactions to human immune serum globulin in Sweden (1969-1978) pp 143-150. Immunoglobulins: Characteristics and uses of intravenous preparations. Alving, B.M. and Finlayson, J.S., Editors. U.S. Dept. Health & Human Services, DHHS Publ. No. (FDA) 80-9005, Wash., D.C., 1980.Google Scholar